NCT02945800 2026-04-02Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory SarcomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed59 enrolled 11 charts
NCT03507491 2024-10-04Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid TumorsEmory UniversityPhase 1 Completed24 enrolled